Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Odyssey Therapeutics, Inc. (ODTX)

NASDAQ

$21.99

$-2.28

(-9.40%)

Pre-Market

Odyssey Therapeutics, Inc. (ODTX) Live Price Chart

Last updated: ⁦2026-09-16 12:10:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Odyssey Therapeutics, Inc. (ODTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $21.99, with a market capitalisation of $1.17B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $15.10 to $29.05. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.17B
Open	$24.31
Day's High	$29.05
Day's Low	$15.10
Previous Close	$24.26
Volume	260.43K
Average Volume	255.55K
P/E Ratio	--
52-Week High	$29.05
52-Week Low	$15.10
Dividend Yield	--
Earnings Date	--

Odyssey Therapeutics, Inc. (ODTX) Pre-Market Stock Price

Odyssey Therapeutics, Inc. (ODTX) is trading at $23.64 in pre-market trading as of 2026-09-15 21:38:00, down 2.56% ($0.62) from the previous close of $24.26

Pre-market trading shows how investors are pricing ODTX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Odyssey Therapeutics, Inc. (ODTX) 7-Day Stock Price Change

Over the past seven days, Odyssey Therapeutics, Inc. (ODTX) moved from $28.76 to $21.99, representing a decline of 23.55% ($6.77).

The stock traded between $21.72 and $29.05 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 221.13 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ODTX 52-Week Price Position

Position in Range: 49.4%

52W Low$15.10

52W High$29.05

ODTX is currently trading at $21.99, placing it 49.4% of the way from its 52-week low of $15.10 to its 52-week high of $29.05. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Odyssey Therapeutics, Inc. (ODTX)?

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Odyssey Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange	NASDAQ
Company Website	https://www.odysseytx.com

How to Buy Odyssey Therapeutics, Inc. (ODTX) Stock on MEXC

Eligible investors can buy real shares of Odyssey Therapeutics, Inc. (ODTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ODTX and Place Your Order

Open the RealStocks trading page and search for ODTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Odyssey Therapeutics, Inc. (ODTX) stock price today?

Odyssey Therapeutics, Inc. (ODTX) is currently trading at $ 21.99, down 9.37% ($2.27) from the previous close of $ 24.26. Intraday prices update in real time during regular trading hours.

2.Is ODTX stock going up or down today?

As of 2026-09-15 21:38:00, ODTX is trading at $ 21.99, down 9.37% ($2.27) from its previous close of $ 24.26. The stock has traded between $ 15.10 and $ 29.05 during today’s regular session. Past price movements do not guarantee future results.

3.What is ODTX pre-market price?

As of 2026-09-15 21:38:00, ODTX is trading at $ 23.64 in pre-market trading, down 2.56% ($0.62) from the previous close of $ 24.26. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ODTX after-hours price?

As of 2026-09-15 21:38:00, ODTX is trading at $ 21.99 in after-hours trading, down 9.38% ($2.28) from the regular-session close of $ 24.26. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ODTX stock trading now?

ODTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ODTX sit relative to its 52-week high and low?

Over the past 52 weeks, ODTX has traded between a low of $ 15.10 and a high of $ 29.05. At $ 21.99, the stock is positioned 49.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Odyssey Therapeutics, Inc. in?

Odyssey Therapeutics, Inc. (ODTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Odyssey Therapeutics, Inc.'s market capitalisation and where is it listed?

Odyssey Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.17B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ODTX valued in terms of P/E ratio and EPS?

ODTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Odyssey Therapeutics, Inc. pay a dividend?

Odyssey Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.